Helen Stephens Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,622
Closed -$521K 92
2024
Q2
$521K Buy
1,622
+6
+0.4% +$1.95K 0.18% 56
2024
Q1
$539K Hold
1,616
0.21% 45
2023
Q4
$437K Sell
1,616
-67
-4% -$16.6K 0.2% 48
2023
Q3
$414K Hold
1,683
0.21% 48
2023
Q2
$511K Buy
1,683
+19
+1% +$5.28K 0.26% 44
2023
Q1
$439K Buy
1,664
+3
+0.2% +$762 0.23% 49
2022
Q4
$398K Buy
1,661
+4
+0.2% +$896 0.24% 51
2022
Q3
$305K Sell
1,657
-103
-6% -$20.5K 0.21% 51
2022
Q2
$296K Buy
1,760
+6
+0.3% +$1.29K 0.21% 46
2022
Q1
$440K Hold
1,754
0.3% 38
2021
Q4
$451K Buy
+1,754
New +$429K 0.36% 32

Other funds holding HCA

Helen Stephens Group's HCA Position: Q3 2024 in Review

Helen Stephens Group sold out of HCA Healthcare (HCA) in Q3 2024, closing a stake of 1,622 shares — an estimated $521K sold.

Helen Stephens Group first reported a position in HCA in Q4 2021 and held it in 11 quarters. The position peaked at $539K in Q1 2024. 1,202 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

  • Helen Stephens Group reported no remaining HCA Healthcare position as of Q3 2024 after selling out during the quarter.
  • Helen Stephens Group sold 1,622 HCA Healthcare shares in Q3 2024, an estimated $521K.
  • Helen Stephens Group first reported a position in HCA Healthcare in Q4 2021 and held it in 11 quarters.
  • Helen Stephens Group's HCA Healthcare position peaked at $539K in Q1 2024.
  • 1,202 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on Helen Stephens Group's 13F filing for Q3 2024, filed 8 Oct 2024.